Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_2941280
Proper Citation: (UC Davis/NIH NeuroMab Facility Cat# N308/48R-1, RRID:AB_2941280)
Target Antigen: GluN1/NR1 glutamate receptor
Host Organism: mouse
Clonality: recombinant
Comments:
Originating manufacturer of this product.
This is a mouse IgG1 subclass-switched recombinant monoclonal antibody (R-mAb) derived from AB_2909568
Previous vendor was James Trimmer; University of California at Davis; California; USA.
We found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Anti-GluN1/NR1 glutamate receptor IgG1 subclass-switched recombinant mouse monoclonal antibody N308/48R-1.
No alerts have been found for Anti-GluN1/NR1 glutamate receptor IgG1 subclass-switched recombinant mouse monoclonal antibody N308/48R-1.
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.